is zepbound a tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity FDA Approves Tirzepatide (Zepbound) as

Clinical data from tirzepatide trials shows that discontinuation due to gastrointestinal side effects occurs in fewer than 5% of participants, meaning the vast majority experience symptoms that are manageable and temporary

In most cases, we can offer same-day or next-day mobile appointments

Professional societies like the Obesity Medicine Association (OMA) advise against compounded peptides because they lack clinical trials that prove their safety and efficacy

Working out or playing sports in the heat means that your body will require some extra attention to keep hydrated

Bremelanotide: Uses, Interactions, Mechanism of Action